BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29526923)

  • 1. [New aspects of poly(A) tail shortening of mRNA in controlling heart functions].
    Kuba K
    Nihon Yakurigaku Zasshi; 2018; 151(3):94-99. PubMed ID: 29526923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCR4-NOT deadenylase complex controls Atg7-dependent cell death and heart function.
    Yamaguchi T; Suzuki T; Sato T; Takahashi A; Watanabe H; Kadowaki A; Natsui M; Inagaki H; Arakawa S; Nakaoka S; Koizumi Y; Seki S; Adachi S; Fukao A; Fujiwara T; Natsume T; Kimura A; Komatsu M; Shimizu S; Ito H; Suzuki Y; Penninger JM; Yamamoto T; Imai Y; Kuba K
    Sci Signal; 2018 Feb; 11(516):. PubMed ID: 29438013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State.
    Zheng X; Yang P; Lackford B; Bennett BD; Wang L; Li H; Wang Y; Miao Y; Foley JF; Fargo DC; Jin Y; Williams CJ; Jothi R; Hu G
    Stem Cell Reports; 2016 Nov; 7(5):897-910. PubMed ID: 27746116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(A) tail degradation in human cells: ATF4 mRNA as a model for biphasic deadenylation.
    Jolles B; Jean-Jean O
    Biochimie; 2021 Jun; 185():128-134. PubMed ID: 33775689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central region of CNOT1 and CNOT9 stimulates deadenylation by the Ccr4-Not nuclease module.
    Pavanello L; Hall B; Airhihen B; Winkler GS
    Biochem J; 2018 Nov; 475(21):3437-3450. PubMed ID: 30309886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic deadenylation: regulation of mRNA fate.
    Wiederhold K; Passmore LA
    Biochem Soc Trans; 2010 Dec; 38(6):1531-6. PubMed ID: 21118121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.
    Maryati M; Airhihen B; Winkler GS
    Biochem J; 2015 Jul; 469(1):169-76. PubMed ID: 25944446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation.
    Ezzeddine N; Chang TC; Zhu W; Yamashita A; Chen CY; Zhong Z; Yamashita Y; Zheng D; Shyu AB
    Mol Cell Biol; 2007 Nov; 27(22):7791-801. PubMed ID: 17785442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential functions of the CNOT7/8 catalytic subunits of the CCR4-NOT complex in mRNA regulation and cell viability.
    Mostafa D; Takahashi A; Yanagiya A; Yamaguchi T; Abe T; Kureha T; Kuba K; Kanegae Y; Furuta Y; Yamamoto T; Suzuki T
    RNA Biol; 2020 Mar; 17(3):403-416. PubMed ID: 31924127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical Modeling of mRNA Poly(A) Tail Shortening Process.
    Fabia B; Kim M; Lim J; Lee YS
    Methods Mol Biol; 2024; 2723():303-317. PubMed ID: 37824078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deadenylation kinetics of mixed poly(A) tails at single-nucleotide resolution.
    Lee YS; Levdansky Y; Jung Y; Kim VN; Valkov E
    Nat Struct Mol Biol; 2024 May; 31(5):826-834. PubMed ID: 38374449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNOT3 contributes to early B cell development by controlling Igh rearrangement and p53 mRNA stability.
    Inoue T; Morita M; Hijikata A; Fukuda-Yuzawa Y; Adachi S; Isono K; Ikawa T; Kawamoto H; Koseki H; Natsume T; Fukao T; Ohara O; Yamamoto T; Kurosaki T
    J Exp Med; 2015 Aug; 212(9):1465-79. PubMed ID: 26238124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA deadenylation complexes in development and diseases.
    Liu Y; Ramkumar N; Vu LP
    Biochem Cell Biol; 2023 Apr; 101(2):131-147. PubMed ID: 36645883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression.
    Passmore LA; Coller J
    Nat Rev Mol Cell Biol; 2022 Feb; 23(2):93-106. PubMed ID: 34594027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CNOT3 in mitotic progression through inhibition of MAD1 expression.
    Takahashi A; Kikuguchi C; Morita M; Shimodaira T; Tokai-Nishizumi N; Yokoyama K; Ohsugi M; Suzuki T; Yamamoto T
    Biochem Biophys Res Commun; 2012 Mar; 419(2):268-73. PubMed ID: 22342980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of recombinant human CCR4-NOT reveals molecular insights into regulated deadenylation.
    Raisch T; Chang CT; Levdansky Y; Muthukumar S; Raunser S; Valkov E
    Nat Commun; 2019 Jul; 10(1):3173. PubMed ID: 31320642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR4, a 3'-5' poly(A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase.
    Chen J; Chiang YC; Denis CL
    EMBO J; 2002 Mar; 21(6):1414-26. PubMed ID: 11889047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of poly(A) tail length.
    Eckmann CR; Rammelt C; Wahle E
    Wiley Interdiscip Rev RNA; 2011; 2(3):348-61. PubMed ID: 21957022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deadenylation of mRNA by the CCR4-NOT complex in Drosophila: molecular and developmental aspects.
    Temme C; Simonelig M; Wahle E
    Front Genet; 2014; 5():143. PubMed ID: 24904643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription Dynamics Regulate Poly(A) Tails and Expression of the RNA Degradation Machinery to Balance mRNA Levels.
    Slobodin B; Bahat A; Sehrawat U; Becker-Herman S; Zuckerman B; Weiss AN; Han R; Elkon R; Agami R; Ulitsky I; Shachar I; Dikstein R
    Mol Cell; 2020 May; 78(3):434-444.e5. PubMed ID: 32294471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.